https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Vascular-MC.jpg

Peripherally Inserted Central Catheters Market Analysis | China | 2017-2023 | MedCore

  • Year: 2017
  • Scope: 2013-2023
  • Region: China
  • Pages: 375
  • Published Date: 2/1/2017
  • Type: MedCore

Although power-injectable PICCs have become the standard of care in some countries such as the U.S., China still prefers conventional PICCs and is over ten years behind most developed countries. In 2016, power-injectable PICCs represented a relatively small portion of the total market for PICCs, with the remaining balance represented by non-power-injectable PICCs. Growth in the unit sales of advanced materials PICCs is expected to drive gains in the share of power-injectable PICCs over the forecast period.

The Chinese market for peripherally inserted central catheters (PICCs) is split up into two segments: power-injectable and non-power-injectable PICCs. Non-power-injectable PICCs are defined as PICCs that do not feature power-injection or antimicrobial properties.

Segments Covered in This Market

  • Conventional PICC Market
  • Power-Injectable PICC Market

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Companies Analyzed

C. R. Bard has been active in growing the PICC market globally by offering educational services to spread awareness about PICCs. Teleflex acquired Arrow International in 2007 and now sells Arrow’s former line of products, which includes power-injectable PICCs and triple lumen power-injectable PICCs. Other companies include B. Braun and Cook Medical.

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled China Market Report Suite for Vascular Access Devices and Accessories – MedSuite

Learn More about these product types

TABLE OF CONTENTS I
LIST OF FIGURES XVI
LIST OF CHARTS XX
EXECUTIVE SUMMARY 1
CHINA VASCULAR ACCESS DEVICE AND ACCESSORIES MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 5
MARKET DEVELOPMENTS 6
MARKETS INCLUDED 7
KEY REPORT UPDATES 8
VERSION HISTORY 8
RESEARCH METHODOLOGY 9
1.1 RESEARCH SCOPE 9
1.2 IDATA’S 9-STEP METHODOLOGY 9
1.2.1 Step 1: Project Initiation & Team Selection 9
1.2.2 Step 2: Prepare Data Systems and Perform Secondary Research 11
1.2.3 Step 3: Preparation for Interviews & Questionnaire Design 12
1.2.4 Step 4: Performing Primary Research 13
1.2.5 Step 5: Research Analysis: Establishing Baseline Estimates 15
1.2.6 Step 6: Market Forecast and Analysis 16
1.2.7 Step 7: Identify Strategic Opportunities 18
1.2.8 Step 8: Final Review and Market Release 19
1.2.9 Step 9: Customer Feedback and Market Monitoring 20
DISEASE OVERVIEW 21
2.1 BASIC ANATOMY 21
2.1.1 Human Vascular System 21
2.2 VASCULAR PATHOLOGY AND DISORDERS 22
2.2.1 Cancer 22
2.2.2 End-Stage Renal Disease 23
2.2.3 Diabetes 25
PRODUCT ASSESSMENT 28
3.1 PRODUCT PORTFOLIOS 28
3.1.1 Peripherally Inserted Central Catheters 28
3.1.1.1 Introduction 28
3.1.1.1.1 PICC Placement 28
3.1.1.2 AngioDynamics 30
3.1.1.2.1 BioFlo® 30
3.1.1.3 Argon Medical 30
3.1.1.3.1 First PICC™ 30
3.1.1.3.2 L-Cath™ 30
3.1.1.4 B. Braun 30
3.1.1.4.1 V-5™ 30
3.1.1.4.2 Other PICC Offerings 30
3.1.1.5 Cook Medical 30
3.1.1.5.1 Spectrum® 30
3.1.1.5.2 Other PICC Offerings 31
3.1.1.6 C.R. Bard 31
3.1.1.6.1 PowerPICC® 31
3.1.1.6.2 Groshong® 31
3.1.1.6.3 Per-Q-Cath® 31
3.1.1.6.4 Other PICC Offerings 31
3.1.1.7 GaltNeedleTech 31
3.1.1.7.1 SYNERGY™ 31
3.1.1.8 Medcomp 32
3.1.1.8.1 Pro-PICC™ 32
3.1.1.8.2 Vascu-PICC™ 32
3.1.1.9 Neo Medical 32
3.1.1.9.1 Neo-Magic™ 32
3.1.1.9.2 V-Cath™ 32
3.1.1.10 PFM Medical 32
3.1.1.10.1 pfm CT PICC II 32
3.1.1.11 Teleflex Medical 32
3.1.1.11.1 ARROW® 32
3.1.1.12 Trinity Sterile 33
3.1.1.12.1 Trinity™ PICC II 33
3.1.1.13 Vygon 33
3.1.1.13.1 Premicath™ 33
3.1.1.13.2 Epicutaneo-Cava™ 33
3.1.1.13.3 Nutriline™ 33
3.1.1.13.4 Lifecath™ 33
3.2 REGULATORY ISSUES AND RECALLS 34
3.2.1 November 2015 34
3.2.2 October 2015 34
3.2.3 September 2015 35
3.2.4 August 2015 37
3.2.5 July 2015 38
3.2.6 April 2015 40
3.2.7 March 2015 41
3.2.8 February 2015 42
3.2.9 January 2015 42
3.2.10 December 2014 43
3.2.11 October 2014 44
3.2.12 September 2014 45
3.2.13 May 2014 46
3.2.14 April 2014 46
3.2.15 March 2014 47
3.2.16 January 2014 47
3.2.17 December 2013 48
3.2.18 September 2013 49
3.2.19 August 2013 50
3.2.20 June 2013 50
3.2.21 March 2013 51
3.2.22 February 2013 52
3.2.23 December 2012 52
3.2.24 August 2012 52
3.2.25 June 2012 53
3.2.26 May 2012 54
3.2.27 March 2012 55
3.2.28 February 2012 56
3.2.29 January 2012 56
3.3 CLINICAL TRIALS 60
3.3.1 Peripherally Inserted Central Catheters 61
3.4 PRODUCT PIPELINES 71
3.4.1 Alliance Vascular Devices, LLC 71
3.4.1.1 FreeHand Safety Huber Needle® 71
3.4.2 AngioDynamics 71
3.4.2.1 Celerity™ PICC Tip Confirmation System with Navigation 71
3.4.2.2 Firefly 71
3.4.2.3 BioFlo® PICC Line Extension 72
3.4.2.4 BioFlo® Port Line Extension 72
3.4.2.5 Next Generation BioFlo® PICC 72
3.4.2.6 Next Generation BioFlo® Port 72
3.4.3 Bluegrass Vascular Technologies, Inc. 72
3.4.3.1 Surfacer® Inside-Out™ Access System 72
3.4.4 C.R. Bard 72
3.4.4.1 Chemical-Resistant PICCs 72
3.4.4.2 Novel Advanced Material PICCs 73
3.4.4.3 PowerGlide® Pro Midline 73
3.4.4.4 AccuCath® 73
3.4.4.5 Xenesis™ Acute Hemodialysis Catheter 73
3.4.4.6 Site~Rite® 8 Ultrasound System 73
3.4.5 M. C. Johnson 73
3.4.5.1 PICC Securement Device 73
3.4.6 Nipro Medical 74
3.4.6.1 Shielding Safety Needle 74
3.4.6.2 Safety Syringe 74
3.4.6.3 Safety PIVC 74
3.4.7 Parasol Medical 74
3.4.7.1 Catheter Securement Device 74
3.4.8 PAVmed Inc. 74
3.4.8.1 NextCath™ 74
3.4.9 Phase One Medical 74
3.4.9.1 Goldilocks™ Long Term Hemodialysis Catheter 74
3.4.9.2 Triple-Lumen Symetrex™ Hemodialysis Catheter 75
3.4.10 Prodigy Diabetes Care, LLC. 75
3.4.10.1 Insulin Pen Needles 75
3.4.11 Sharklet Technologies, Inc. 75
3.4.11.1 Sharklet™ Central Venous Catheter 75
3.4.12 Starboard Medical 75
3.4.12.1 Catheter Securement Devices 75
3.4.13 Teleflex Medical 76
3.4.13.1 Arrow® Endurance™ Extended Dwell Peripheral Catheter System 76
3.4.13.2 Tip Confirmation for CVCs, Chronic Hemodialysis Catheters & Ports 76
3.4.14 Vascular Access Technologies, Inc. 76
3.4.14.1 SAFECVAD™ 76
PERIPHERALLY INSERTED CENTRAL CATHETER MARKET 77
4.1 MARKET OVERVIEW 77
4.2 MARKET ANALYSIS AND FORECAST 81
4.2.1 Total Peripherally Inserted Central Catheter Market 81
4.2.2 Conventional Peripherally Inserted Central Catheter Market 83
4.2.3 Power-Injectable Peripherally Inserted Central Catheter Market 85
4.3 DRIVERS AND LIMITERS 87
4.3.1 Market Drivers 87
4.3.2 Market Limiters 88
4.4 COMPETITIVE MARKET SHARE ANALYSIS 90
ABBREVIATIONS 93
APPENDIX: COMPANY PRESS RELEASES 94
The "China Market Report Suite for Vascular Access Devices and Accessories 2017 - MedSuite" includes analysis on the following companies currently active in this market:
CR Bard
Teleflex
BD
B Braun
Smiths Medical
Medtronic
Cook Medical
Others include: Changzhou Yuandong Medical, Henan Concerone Industry Co., Heze Sinorgmed Polymers Co., Jiangsu Province Huaxing Medical, Jiangxi Sanxin Medtec Co., Lepu Medical Technology, Longreal Medevice Limited, Melson Medical Corporation Limited, Nanjing Hoshin Medical Instrument Co., Ningbo Win-Win Medical Instruments, Poweam Medical, Qingdao Joyjun Medical Products Co, Qingdao Medical Import & Export Co., Shandong Sinorgmed Co., Ltd., Shanghai Hengxin Medical Devices, Shanghai Madicare Co., Zibo Eastmed Healthcare Products, etc
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.
Chart 1 1: Vascular Access Device and Accessories Market by Segment China, 2013 – 2023 2
Chart 1 2: Vascular Access Device and Accessories Market China, 2016 & 2023 2
Chart 4 1: Peripherally Inserted Central Catheter Market by Segment, China, 2013 – 2023 79
Chart 4 2: Peripherally Inserted Central Catheter Market Breakdown, China, 2016 80
Chart 4 3: Peripherally Inserted Central Catheter Market Breakdown, China, 2023 80
Chart 4 4: Total Peripherally Inserted Central Catheter Market, China, 2013 – 2023 82
Chart 4 5: Conventional Peripherally Inserted Central Catheter Market, China, 2013 – 2023 84
Chart 4 6: Power-Injectable Peripherally Inserted Central Catheter Market, China, 2013 – 2023 86
Chart 4 7: Leading Competitors, Peripherally Inserted Central Catheter Market, China, 2016 92

Figure 1 1: Leading Competitors by Segment, Vascular Access Device and Accessories Market, China, 2016 (1 of 2) 3
Figure 1 2: Leading Competitors by Segment, Vascular Access Device and Accessories Market, China, 2016 (2 of 2) 4
Figure 1 3: Companies Researched in this Report, China, 2016 4
Figure 1 4: Factors Impacting the Vascular Access Device and Accessories Market, China 5
Figure 1 5: Recent Events in the Vascular Access Device and Accessories Market, China, 2012 – 2016 6
Figure 1 6: Vascular Access Device and Accessories Markets Covered, China, 2016 7
Figure 1 7: Key Report Updates 8
Figure 1 8: Version History 8
Figure 3 1: Class 2 Device Recall Medtronic 34
Figure 3 2: Class 2 Device Recall Smiths Medical 34
Figure 3 3: Class 2 Device Recall Arrow 35
Figure 3 4: Class 2 Device Recall Arrow 35
Figure 3 5: Class 2 Device Recall Covidien (Medtronic) 36
Figure 3 6: Class 2 Device Recall Arrow 37
Figure 3 7: Class 2 Device Recall Medline 37
Figure 3 8: Class 2 Device Recall Arrow 37
Figure 3 9: Class 2 Device Recall B. Braun 37
Figure 3 10: Class 3 Device Recall Bard Access 38
Figure 3 11: Class 2 Device Recall Covidien (Medtronic) 38
Figure 3 12: Class 2 Device Recall Bard Access 40
Figure 3 13: Class 2 Device Recall Bard Access 40
Figure 3 14: Class 2 Device Recall Medcomp & AngioDynamics 41
Figure 3 15: Class 2 Device Recall Bard Access 41
Figure 3 16: Class 2 Device Recall Arrow 42
Figure 3 17: Class 2 Device Recall Medcomp 42
Figure 3 18: Class 2 Device Recall Arrow 42
Figure 3 19: Class 2 Device Recall Arrow 43
Figure 3 20: Class 2 Device Recall Smiths Medical 43
Figure 3 21: Class 2 Device Recall PFM Medical 43
Figure 3 22: Class 2 Device Recall PFM Medical 43
Figure 3 23: Class 2 Device Recall Becton Dickinson 44
Figure 3 24: Class 2 Device Recall Arrow 44
Figure 3 25: Class 2 Device Recall Arrow 44
Figure 3 26: Class 2 Device Recall Navilyst Medical 44
Figure 3 27: Class 2 Device Recall Argon Medical 45
Figure 3 28: Class 2 Device Recall Arrow 46
Figure 3 29: Class 2 Device Recall Arrow 46
Figure 3 30: Class 2 Device Recall Arrow 47
Figure 3 31: Class 2 Device Recall Bard Access 47
Figure 3 32: Class 2 Device Recall Navilyst Medical 47
Figure 3 33: Class 2 Device Recall Bard Access 48
Figure 3 34: Class 2 Device Recall Smiths Medical 48
Figure 3 35: Class 2 Device Recall B. Braun 48
Figure 3 36: Class 2 Device Recall Smiths Medical 49
Figure 3 37: Class 2 Device Recall Access Scientific 49
Figure 3 38: Class 2 Device Recall Covidien (Medtronic) 49
Figure 3 39: Class 2 Device Recall Arrow 50
Figure 3 40: Class 2 Device Recall Bard Access 50
Figure 3 41: Class 2 Device Recall Becton Dickinson 50
Figure 3 42: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 51
Figure 3 43: Class 2 Device Recall Bard Access 51
Figure 3 44: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 51
Figure 3 45: Class 2 Device Recall Medcomp 52
Figure 3 46: Class 2 Device Recall Becton Dickinson 52
Figure 3 47: Class 3 Device Recall Bard Access 52
Figure 3 48: Class 2 Device Recall Medcomp 53
Figure 3 49: Class 1 Device Recall Arrow 53
Figure 3 50: Class 2 Device Recall Arrow 53
Figure 3 51: Class 2 Device Recall Vygon 53
Figure 3 52: Class 2 Device Recall Covidien (Medtronic) 54
Figure 3 53: Class 2 Device Recall Medcomp 55
Figure 3 54: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 55
Figure 3 55: Class 2 Device Recall Christie Medical Holdings 55
Figure 3 56: Class 3 Recall Bard Access 55
Figure 3 57: Class 2 Device Recall AngioDynamics 56
Figure 3 58: Class 2 Device Recall Becton Dickinson 56
Figure 3 59: Class 2 Device Recall AngioDynamics 56
Figure 3 60: Class 2 Device Recall AngioDynamics 58
Figure 3 61: Class 3 Device Recall AngioDynamics 59
Figure 3 62: Class 2 Device Recall AngioDynamics 59
Figure 3 63: A Pragmatic Randomized Trial Standard of Care Vascular Access Strategies 61
Figure 3 64: PICC and Midline Related Complications: A Multicenter Observational Study 62
Figure 3 65: Complications Associated With Central Venous Access 62
Figure 3 66: Evaluation of Electrocardiographic Guidance 62
Figure 3 67: Phase II Randomised Study Comparing the Tolerance of PICC Line 63
Figure 3 68: Randomized, Prospective, Single-center Study 63
Figure 3 69: A Randomized Controlled Trial Comparing Ultrasound Guided PICC Line Insertion 64
Figure 3 70: Ultrasound-guided Peripheral Vascular Access 64
Figure 3 71: Vascular Access in Cancer Patients 65
Figure 3 72: A Monocenter Prospective Study 66
Figure 3 73: Vascular Access in Hematological Patients 66
Figure 3 74: ECG Versus Ultrasound-guided Positioning of the Peripherally Inserted Central Catheter (PICC) Tip 66
Figure 3 75: Sequential Pneumatic Compression 67
Figure 3 76: Reliability of Central Venous Pressure Measurements 67
Figure 3 77: Time and Motion Related to PICC Insertion Process and Catheter Tip Confirmation 68
Figure 3 78: A Randomized Open-labeled Multicenter Study 68
Figure 3 79: A Phase III Study of Peripherally Inserted Versus Centrally Inserted Central Venous Catheters 69
Figure 3 80: A Randomized Prospective Multicenter Evaluation 69
Figure 3 81: Randomized Double Blind Comparison 70
Figure 3 82: An Observational, Prospective, Single-center Study of Placement and Confirmation 70
Figure 4 1: Peripherally Inserted Central Catheter Market by Segment, China, 2013 – 2023 (US$M) 78
Figure 4 2: Peripherally Inserted Central Catheter Market by Segment, China, 2013 – 2023 (CN¥M) 78
Figure 4 3: Total Peripherally Inserted Central Catheter Market, China, 2013 – 2023 81
Figure 4 4: Conventional Peripherally Inserted Central Catheter Market, China, 2013 – 2023 83
Figure 4 5: Power-Injectable Peripherally Inserted Central Catheter Market, China, 2013 – 2023 85
Figure 4 6: Drivers and Limiters, Peripherally Inserted Central Catheter Market, China, 2016 89
Figure 4 7: Leading Competitors, Peripherally Inserted Central Catheter Market, China, 2016 91
Figure 6 1: Press Release Summary 94

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology